Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by cognitive decline, formation of the extracellular amyloid β (Aβ42) plaques, neuronal and synapse loss, and activated microglia and astrocytes. Extracellular chaperones, which are known to inhibit amyloid fibril formation and promote clearance of misfolded aggregates, have recently been shown to reduce efficiently the toxicity of HypF-N misfolded oligomers to immortalised cell lines, by binding and clustering them into large species. However, the role of extracellular chaperones on Aβ oligomer toxicity remains unclear, with reports often appearing contradictory. In this study we microinjected into the hippocampus of rat brains Aβ42 oligomers preincubated for 1 h with two extracellular chaperones, namely clusterin and α2-macroglobulin. The chaperones were found to prevent Aβ42-induced learning and memory impairments, as assessed by the Morris Water Maze test, and reduce Aβ42-induced glia inflammation and neuronal degeneration in rat brains, as probed by fluorescent immunohistochemical analyses. Moreover, the chaperones were able to prevent Aβ42 colocalisation with PSD-95 at post-synaptic terminals of rat primary neurons, suppressing oligomer cytotoxicity. All such effects were not effective by adding pre-formed oligomers and chaperones without preincubation. Molecular chaperones have therefore the potential to prevent the early symptoms of AD, not just by inhibiting Aβ42 aggregation, as previously demonstrated, but also by suppressing the toxicity of Aβ42 oligomers after they are formed. These findings elect them as novel neuroprotectors against amyloid-induced injury and excellent candidates for the design of therapeutic strategies against AD. These findings elect them as novel neuroprotectors against amyloid-induced injury and excellent candidates for the design of therapeutic strategies against AD.
Introduction
Alzheimer's disease (AD) is a progressive human neurodegenerative disorder characterised by cognitive decline, neuronal and synapse loss, and the formation of two pathological lesions, extracellular amyloid plaques composed largely of the amyloid- peptide (Aβ), and intracellular neurofibrillary tangles formed by the hyperphosphorylated tau protein [1] . Impairment in synaptic function and plasticity might be the most significant early event in the pathogenesis of AD [2, 3] , with such events being particularly relevant in the hippocampal region [4] .
Clinicopathological hallmarks of AD correlate with the presence of soluble Aβ oligomers as the principal neurotoxic agent [2, 5, 6] . It has been demonstrated that synaptic plasticity is rapidly disrupted by Aβ 42 oligomers [7] [8] [9] [10] [11] [12] . Moreover, Aβ oligomers have been found to colocalize with postsynaptic density protein 95 (PSD-95) in hippocampal and cortical primary neurons [13] [14] [15] and impair cognitive functions of animal models when microinjected in their brains [5, 16] . PSD-95 is a critical scaffolding component of postsynaptic terminals found in excitatory Central Nervous System (CNS) signaling pathways [17] and clusters of PSD-95 have been established previously as definitive markers for postsynaptic terminals in mature hippocampal and cortical cell cultures [18] [19] [20] . In addition, the concentration of PSD-95 in the brain of AD patients is significantly lower than that of normal brains [21] . Aβ also plays a central role in the pathogenesis of AD as a mediator of oxidative stress and neuronal cell apoptosis [22] [23] [24] [25] [26] [27] [28] [29] .
Neurons are not the only cell type in the brain that is affected in AD; vulnerable brain regions exhibit activated microglial cells and astrocytes, which often associate with amyloid deposits suggesting a central role of these non-neuronal cells in AD pathology [30] [31] [32] [33] . It has also been suggested that atrophy of astroglia, which occurs at the early stages of AD and is likely to accompany early stages of other neurodegenerative diseases, determines synaptic malfunction, synaptic loss, and cognitive deficits [34] .
Molecular chaperones are proteins that play a central role in the avoidance of protein misfolding and aggregation [35, 36] . Chaperones are known to have a range of different functions, such as assisting protein folding [35] , inhibiting protein aggregation [37] , causing the disaggregation of aberrant protein oligomers [38] , and facilitating the degradation of misfolded proteins [39] . In particular, extracellular chaperones, such as clusterin (Clu), haptoglobin (Hp) and α 2 -macroglobulin (α 2 M), have been shown to colocalize with amyloid plaques in AD [40] [41] [42] , inhibit Aβ fibril formation in vitro [43] [44] [45] [46] [47] and promote the clearance of protein aggregates via endocytosis [48] [49] [50] . It is unclear, however, whether extracellular chaperones inhibit directly the toxicity of A oligomers, as reports have often been contradictory, with a few of them supporting a toxicity-enhancing role [7, 51, 52] , others claiming a protective action [43, 53, 54] and one report describing a dose-dependent effect [46] .
Our recent data showed that a representative set of chaperones can inhibit efficiently the toxicity of extracellularly added protein oligomers formed by three different peptides and proteins in SH-SY5Y neuroblastoma cells, provided the chaperones are incubated with the preformed oligomers before the resulting mixtures are added to the extracellular medium of the cells [54] . Such an inhibition is very effective as it occurs even at low chaperone concentration [54] . Using preformed HypF-N oligomers as a representative toxic species, the protective effect of the chaperones was shown to result from the ability of these proteins to bind to the oligomers and promote their further assembly into larger species, in the absence of any significant reorganisation of their internal molecular structure [54] .
Following this encouraging result obtained with HypF-N oligomers and cultured neuronal cells, the purpose of this study was to determine whether pre-incubation of Aβ 42 oligomers with two types of extracellular chaperones can prevent Aβ 42 -induced hippocampal injury in rats following hippocampal microinjection and to determine how it correlates with reduced brain pathology and behavioural injuries. In these experiments, toxic oligomers from Aβ 42 were formed, incubated with Clu or α 2 M, and then injected into rat brains or added to the extracellular medium of rat primary neurons. Thus, the oligomers were formed before adding the chaperones, with the aim of assessing whether the protective action of the latter also includes neutralisation of toxic oligomers after they have formed. We demonstrate that the chaperones ameliorate the Aβ 42 -mediated learning and memory impairment in injected rats, reduce Aβ 42 -induced glia inflammation and neuronal degeneration in injected rat brains and protect against the oxidative-stress conditions and apoptotic cell death associated with Aβ 42 exposure. In addition, the extracellular chaperones were found to prevent Aβ 42 binding to PSD-95 in dendritic spines, neutralising oligomer toxicity in cultured rat primary neurons.
Materials and Methods

Formation of Aβ 42 oligomers
A 42 were obtained from Sigma-Aldrich (St. Louis, MO). Human Clu and α 2 M were purified as previously reported [55, 56] . Aβ 42 oligomers were prepared as previously described [57] and resuspended in F12-medium to 12 μM. Native proteins were diluted to 12 μM into the same medium. Oligomers were incubated in the medium for 1 h at 37 °C while shaking, without or with chaperones, and then injected into rats or added to cultured cells.
The oligomer:chaperone molar ratio was 10:1 for Clu and 100:1 for α 2 M (Aβ 42 is considered as monomers, Clu as α dimers and α 2 M as a tetramer, according to the functional oligomeric state).
Rat model and cell cultures
Thirty-six three-month-old (220-250 g) male Wistar rats (Harlan Nossan, Correzzana, Italy) were housed in macrolon cages until surgery and maintained on a 12-hour light/dark cycle at 23 °C. All animal manipulations were performed in vivo, according to the European Community guidelines for animal care (DL 116/92).
Primary cortical and hippocampal neurons were obtained from embryonic day (ED)-17
Sprague-Dawley rats (Harlan) as described in Bongers et al. [58] . The experimental procedures were in accordance with the standards set forth in the Guide for the Care and Use of Laboratory Animals (published by the National Academy of Science, National Academy Press, Washington, D.C.). The uteri were removed from the gravid rat under anaesthesia. /well, respectively. Cultures were maintained in NBM at 37° C in a 5% CO 2 -humidified atmosphere. Neurons were exposed to 12 μM toxic oligomers 14 days after plating.
Morris water maze test (MWM)
For in vivo studies, Aβ 42 oligomers and chaperones were suspended in F12-medium with 0.1% DMSO at final concentrations of 0.45 mg/ml (100 µM) and 0.7 mg/ml (10 µM for Clu and 1 µM for α 2 M), respectively, and incubated for 1 h at 37 °C while shaking. 1.5 µl   aliquots of F12-medium, F12-medium with Aβ 42 oligomers, F12-medium with Aβ 42 oligomers and Clu and F12-medium with Aβ 42 oligomer and α 2 M, all containing 0.1% DMSO, were injected into the Cornu Ammonis (CA) 1 molecular layer of the right hippocampus of anaesthetised (Zoletyl, 45 mg/kg plus Carprofen, 5 mg/kg) rats for each condition, using a Hamilton microsyringe, at the following stereotaxic coordinates (in mm): AP,-3.7; L,-2.5 from bregma; and H, 3.5 below the dura [59] . The injections lasted 3 min, and the microsyringe was left in the place for 5 min after completing the infusion. Rats were behaviourally tested in the MWM 1 week after the intrahippocampal injection of the different oligomers (n=6/group). This was considered a reasonable time period to allow us to detect long-term effects of the injected aggregates in light of their likely persistence in tissue.
The water maze apparatus consisted of a circular pool (160 cm diameter and 45 cm high) made of plastic. The pool was filled to a depth of 30 cm with water (22±1 °C) that was made dark by the addition of non-toxic dark paint, and virtually divided into four equivalent quadrants. Rats were tested in the reference memory version of MWM with the procedure previously described [60] ; briefly, all rats underwent a reference memory training with a hidden platform (13 cm diameter, submerged 0.5 cm under the water level), placed in the centre of one quadrant of the pool (northwest) for 4 days, with 4 trials per day, with the four starting locations varied between trials. Upon release into the water, the rat was allowed to search the platform for 60 s; if the platform was not located within the maximum time of 60 s, the rat was guided to the location. The rat was allowed 20 s on the platform. Extra-maze visual cues around the room remained in fixed positions throughout the experiment. For each trial, latency to find the platform (maximum 60 s) was recorded by a videotracking/computer-digitising system (HVS Image, Hampton, UK). On day 4, five hours after the last trial, the platform was removed from the pool and each rat received one 30 s swim "probe trial". The starting point was set in the south-east quadrant. Percentage of time spent in each quadrant and the number of crossing over the platform section were recorded.
Fluorescence immunohistochemical analyses of glial activation and Neu-N
After behavioural evaluations, all rats were deeply anaesthetised with chloral hydrate (400 mg/kg, i.p.) and killed by decapitation. Four brains for each conditions were quickly extracted and fixed in phosphate-buffered 4% paraformaldehyde (pH 7.4) for 24 h at 4 °C, subsequently rinsed with PBS, dehydrated using an automated machine and embedded in paraffin. Coronal sections (5.0 µm) were cut using a microtome and mounted on slides.
Sections were then incubated in xylene for 20 min at room temperature, to allow removal of paraffin, and subsequently rehydrated. Fluorescent labeling followed previously described protocols [61] . Briefly, 5 µm paraffin- 
Lipid peroxidation analysis and caspase-3 activity assay in rat hippocampus
The analyses of lipid peroxidation and caspase-3 levels were performed on rat hippocampal homogenates. We microinjected 1.5 µl aliquots of F12-medium, Aβ 42 oligomers and Aβ 42 oligomer pre-incubated with Clu or α 2 M for 0 h and 1 h, into the right hippocampus of anaesthetised rats. Three hippocampi for each condition were quickly extracted from rat brains and immediately stored at -80 °C. Each hippocampus was transferred to ice-cold microcentrifuge tubes with 200 µl of lysis buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM EGTA, 5 mM EDTA, 2 mM sodium pyrophosphate, 4 mM para-nitrophenylphosphate, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride (PMSF), plus 20 µg/ml leupeptin and 30 µg/ml aprotinin), and tissues were homogenised on ice (with a PotterElvehjem homogeniser) directly into the Eppendorf tube (20 strokes, 1 stroke/s). Immediately after homogenisation, protein determination was performed using the method of Bradford [62] . To assess the rate of lipid peroxidation, the 8-OH isoprostane levels were measured in rat hippocampal homogenates (5 µg of proteins per well) using the 8-isoprostane EIA kit (Cayman Chemical Company, Ann Arbor, MI) at 405 nm, as previously described [63] .
The caspase-3 activity assay homogenates were prepared using a different buffer composition (20 mM Tris-HCl buffer, pH 7.4, containing 250 mM NaCl, 2 mM EDTA, 0.1% Triton X-100, 5 µg/ml aprotinin, 5 µg/ml leupeptin, 0.5 mM phenylmethylsulfonyl fluoride, 4 mM sodium vanadate, and 1 mM dithiothreitol (DTT)) [64] . To evaluate the caspase-3 activation, 50 μg of total proteins were diluted in 50 mM HEPES-KOH buffer, pH 7.0,
propanesulfonate, 2 mM EDTA, 10 mM DTT and incubated for 4 h at 37 °C in presence of 30 μM Ac-DEVD-AFC (excitation, 400 nm; emission, 505 nm) (Biomol Research Laboratories Inc., Plymouth Meeting, PA, http://www.biomol.com).
MTT reduction assay in cultured neurons
To assess the effects of chaperones on the Aβ 42 oligomer cytotoxicity, we evaluated the mitochondrial status using the 3- 
Measurement of intracellular ROS in cultured neurons
Preformed oligomers of Aβ 42 (12 µM monomer concentration) were incubated for 0 h and 1 h in the cell culture medium with or without Clu or α 2 M (oligomer:chaperone molar ratios as described above) and then added to rat neurons seeded on glass coverslips for 60 min at 37
°C. To detect intracellular ROS production, neurons were then loaded with 10 µM 2',7'-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA, Molecular Probes), as described previously [66] . Cell fluorescence was analyzed by the confocal scanning microscope described above using the 488 nm excitation line.
Colocalization of Aβ 42 aggregates with PSD-95 in cultured neurons
Preformed oligomers of Aβ 42 (12 µM monomer concentration) were incubated for 1 h in the cell culture medium with or without Clu or α 2 M (Aβ 42 :chaperone molar ratio as described above) and then added to rat neurons seeded on glass coverslips for 1 h or 24 h at 37 °C.
Immunolabeling of cultured primary neurons was performed as previously described [14] . 
Statistical analysis
MWM data are expressed as mean ± standard error of the mean (SEM). MTT test, 8-OH
isoprostane test and caspase-3 assay were expressed as mean  standard deviation (SD).
Comparisons between different groups were performed using ANOVA followed by
Bonferroni's post-comparison test. A p-value less than 0.05 was accepted as statistically significant.
RESULTS
Chaperones prevented learning and memory impairment in intra-hippocampus Aβ 42 injected rats
Aβ 42 oligomers were incubated for 1 h in F-12 medium in the absence or presence of two types of extracellular chaperones, namely clusterin (Clu) and α 2 -macroglobulin (α 2 M). 1.5 µl aliquots (0.7 µg Aβ 42 with. 1 µg Clu or α 2 M) were microinjected into the right hippocampus of rat brains. Seven days after unilateral injection into the hippocampus, rats were trained for four days in the Morris water maze (MWM) to learn where the hidden platform was located.
The ability of rats to acquire, process, and recall spatial information was assessed by evaluation of the time required to find the platform (escape latency), time in quadrant where the platform is located (target quadrant), time in the opposite quadrant, time in the small area where the platform is located (platform section) and number of crossings over the platform section. The animals were naive to the water maze and showed no deficiencies in swimming abilities, directional swimming toward the platform, or climbing onto a hidden platform during training trials. Rats injected only with F12-medium shortened the escape latency during the 4-days training phase (Fig. 1A ). They were good swimmers and responded to being placed in water with an appropriate swim-search response. Conversely, Aβ 42 oligomerinjected rats showed only a slow decrease in escape latency during the 4 days of training ( (Fig. 1B, bottom left) . Finally, the number of crossings over the platform position revealed a significant increase in rats injected with (Fig. 2) . Such a decrease was evident by monitoring both GFAPimmunoreactive astrocytes ( Fig. 2A) and Iba 1-labelled microglial cells (Fig. 2B ).
Hypertrophic astrocytes with long, thick branches were detected by GFAP immunostaining in Aβ 42 -injected rats ( Fig. 2A) . In contrast, in rats treated with Aβ 42 and chaperones, astrocyte activation occurred to a much lesser extent ( Fig. 2A) . Labeling with anti-Iba-1 antibodies revealed microglia with small cell bodies and thin, elongated processes in rats treated with Aβ 42 plus Clu or α 2 M, compared to Aβ 42 -injected rats, where microglia with enlarged cell bodies and short, thickened processes were found (Fig. 2B ). This data therefore suggests that these two extracellular chaperones can protect against the Aβ 42 oligomer-mediated glial inflammation.
Chaperones prevented neuronal degeneration in Aβ 42 exposed rat hippocampus
In AD, the aggregated species of Aβ peptides interact with the plasma membrane of the affected cells, triggering a free radical-mediated injury that ultimately results in cell degeneration [68] . The survival of neurons after treatment with Aβ 42 oligomers plus Clu or α 2 M was examined by using the Neu-N marker. The group injected with Aβ 42 oligomers showed a decreased number of mature neurons compared to the medium-administered group (Fig. 3A) . Conversely, rats treated with Aβ 42 oligomers preincubated for 1h with Clu or α 2 M showed a high improvement in neuron survival, suggesting that chaperones can prevent Aβ 42 -mediated neurodegeneration.
We next evaluated the protective role of the two extracellular chaperones against Aβ 42 -induced lipid peroxidation, determined by measuring 8-OH isoprostane levels. The results
showed that 8-OH isoprostane levels were significantly higher in the hippocampal homogenates of rats treated with Aβ 42 oligomers, compared to the medium-injected groups (Fig. 3B) , suggesting an oxidative-stressed condition associated with Aβ 42 oligomer exposure. 8-OH isoprostane levels were also high after injection of Aβ 42 oligomers with Clu or α 2 M in the absence of pre-incubation (Fig. 3B) . In contrast, the hippocampi of rats treated with Aβ 42 oligomers and either chaperone in the presence of preincubation for 1 h before injection showed no difference in the lipid peroxidation levels with respect to mediuminjected rats (Fig. 3B) .
We then analyzed whether the two chaperones can prevent the Aβ 42 -induced cell death, by measuring the activity of caspase-3, a well-recognised apoptotic marker, in rat hippocampal homogenates [64] . Caspase-3 activation was significantly increased in the hippocampal homogenates of rats injected with Aβ 42 oligomers, with respect to the rats injected only with F12-medium (Fig. 3C ), indicating apoptotic cell death associated with Aβ 42 oligomer treatment. Caspase-3 activation was also increased in the hippocampal homogenates of rats injected with Aβ 42 oligomers plus Clu or α 2 M in the absence of preincubation (Fig. 3C) . On the other hand, the level of caspase-3 activation in hippocampi of rats treated with Aβ 42 oligomers pre-incubated with chaperones for 1 h was not significantly different to that of rats injected only with F12-medium (Fig. 3C ).
These results suggest that the pre-incubation of Aβ 42 oligomers with chaperones prevents the oxidative-stress conditions associated with Aβ 42 oligomer exposure, avoiding the induction of apoptosis by the oligomers.
Chaperones suppress A 42 oligomer-induced cytotoxicity in rat hippocampal and cortical neurons
To assess the protective role of the two extracellular chaperones against Aβ 42 oligomers,
we also used cultures of hippocampal and cortical neurons extracted from embryonic day (ED)-17 rats and analyzed in their mature form at day 21. In a first set of experiments we incubated preformed oligomers of A 42 in the cell culture medium in the absence or presence of Clu or α 2 M for different time lengths, and then added the resulting mixture to the extracellular medium of cultured primary hippocampal neurons. A 42 oligomers showed their toxic action (Fig. 4A) , whereas the neurons treated with oligomers pre-incubated with Clu or α 2 M were found to reduce MTT to levels similar to medium-administered cells ( Fig. 1A and B) . HypF-N is a valuable model system for investigating the structural basis of the cellular dysfunction caused by misfolded protein oligomers, because this protein have the same morphological and tinctorial features as those formed by disease-related peptides and proteins [65] .
Then we compared the ability of the two extracellular chaperones to suppress the intracellular ROS production and Ca 2+ dyshomeostasis induced by A 42 oligomers. A 42 oligomers induced a sharp increase in ROS (Fig. 4C,D) and cytosolic free Ca 2+ (Suppl. Fig.   2 ) in rat neurons, which was inhibited by Clu and α 2 M (Fig. 4C and D and Suppl. Fig. 2 ).
Such inhibitory effects were not found when the oligomers and the chaperones were added to the rat neurons in the absence of pre-incubation (Fig. 4C and Suppl. Fig. 2A ), suggesting the importance of the pre-incubation time. Comparable results were obtained with HypF-N oligomers (Suppl. Fig. 1C and D and Suppl. Fig. 3 ).
These results therefore indicate that pre-incubation of Aβ 42 oligomers with the two chaperones can suppress or decrease markedly the oxidative stress, calcium dishomeostasis and toxicity caused by A 42 .
Chaperones inhibit colocalization of Aβ 42 aggregates with PSD-95 preventing synaptic dysfunction
We next investigated by confocal microscopy whether chaperones prevent the colocalization of Aβ 42 These results show that A 42 oligomers induce a decrease in PSD-95 levels in a timedependent manner, as previously reported with Aβ 40 [69] , supporting a model of AD pathogenesis in which soluble Aβ may be responsible for the cognitive impairment through synaptic dysfunction [3] . In addition, the two extracellular chaperones studied here are able to recover PSD-95 expression, avoiding oligomer binding to the synapses, suggesting an important protective effect of chaperones against oligomer-induced synaptic dysfunction.
DISCUSSION
Clusterin (Clu) and α 2 -macroglobulin (α 2 M) are markedly induced in neuropathological conditions such as AD, where they are found associated with Aβ plaques, suggesting a physiological interaction with Aβ [40] [41] [42] [70] [71] [72] . Clu and α 2 M are also known to inhibit amyloid fibril formation in vitro [43] [44] [45] [46] [47] . In particular, it has been shown that Clu binds to all types of soluble oligomers found to be present during the aggregation and disaggregation of Aβ 40 , preventing further growth and proliferation of aggregated species [73] [74] [75] [76] [77] . α 2 M was also found to bind small oligomers, preventing their growth and/or conversion into fibrils [47] . Furthermore, Clu and α 2 M are known to mediate the clearance of extracellular protein oligomers via endocytosis [48] [49] [50] . It is unclear, however, if extracellular chaperones have an ability to inhibit intrinsically the toxicity of A misfolded oligomers, with evidence that has being very sparse and often contradictory so far. Indeed, some reports supported a toxicityenhancing role for extracellular chaperones [7, 51, 52] , others claimed a protective action [43, 53, 54] while one study demonstrated that the ratio of chaperone:A could determine whether the effect was protective or enhanced toxicity [46] .
Important suggestions have been obtained using chaperones distinct from extracellular ones, or protein oligomers distinct from A oligomers. Indeed, it has been demonstrated that intracellular chaperones can prevent the toxicity of Aβ oligomers, sequestering and converting them into large non toxic aggregates [78] . Our recent data showed that different chaperones, including Clu and α 2 M, can inhibit efficiently the toxicity of extracellularly added protein oligomers formed by three different peptides and proteins in SH-SY5Y neuroblastoma cells, provided the chaperones are incubated with the preformed oligomers before the resulting mixtures are added to the extracellular medium of the cells [54] . Such an inhibition is very effective as it occurs even at low chaperone concentration [54] . Using HypF-N oligomers as a toxic species, the protective effect of the chaperones was found to result from the ability of these proteins to bind to the oligomers and promote their further assembly into larger species, in the absence of any significant reorganisation of their internal molecular structure [54] .
The present work originated from this previous study and was targeted to A oligomers, extracellular chaperones and a context closely related to AD, such as rat brains and cultured neurons. We demonstrated that chaperones can inhibit in vivo the neurotoxicity of high concentrations of pre-formed extracellular A oligomers. Such an ability adds to the wellestablished functions of extracellular chaperones in inhibiting protein aggregation [43] [44] [45] [46] [47] and promoting the clearance of protein aggregates [48] [49] [50] . In all our experiments, the oligomers are formed before adding the chaperones, showing that the protective action of the latter also includes neutralisation of toxic oligomers after they have formed. Thus we can hypothesize that chaperones neutralize A 42 oligomers through a binding mechanism that promote the seeding of larger species, as previously demonstrated with HypF-N oligomers [54] . The accumulation of A fibrils as large plaques visible with optical microscopy and the association of such plaques with extracellular chaperones is indeed suggestive of this possibility.
Multiple lines of evidence indicate that there are two locales in which Aβ oligomers play a role in AD pathogenesis and are implicated in a synaptic failure, namely the intraneuronal and extracellular compartments [79] [80] [81] [82] [83] [84] [85] . A dynamic equilibrium seems to exist between the pools of Aβ oligomers in the two locales; extracellular Aβ appears to originate from intraneuronal Aβ [86] . Since A is released extracellularly from a membrane precursor protein, A plaques accumulate extracellularly and A oligomers have an ability to impair cell viability from the extracellular space, we have chosen to focus on extracellularly added oligomers rather than intracellular ones in all our experiments. This is the first report that molecular chaperones prevent A 42 -induced learning and memory impairments in hippocampal-injected rat brains in vivo. Associated with this prevention is the reduction of astroglial activation, astrogliosis, lipoperoxidation, and caspase-3 activation in these brains. In addition, chaperones were found to be able to protect 22 primary hippocampal and cortical neurons against injuries caused by misfolded A 42 oligomers, by preventing A 42 binding to the dendrites. In future experiments it will be crucial to determine whether chaperone-mediated neutralization of A 42 oligomers also act in transgenic mouse models.
Hence, these data elect extracellular chaperones as novel molecules that are neuroprotective against amyloid-induced injury and excellent candidates for the design and development of therapeutic strategies for the prophylaxis and treatment of AD. and Cristina Cecchi* 1
Supplementary materials
Formation of HypF-N oligomers
HypF-N was expressed, purified, and converted into toxic oligomers as previously reported [60] . Oligomers were resuspended in the cell culture medium to 12 μM. Native proteins were diluted to 12 μM into the same medium. Oligomers were then incubated in the appropriate media 
MTT reduction assay in cultured neurons
To assess the effects of chaperones on the HypF-N oligomer cytotoxicity, we evaluated the mitochondrial status using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, on primary rat hippocampal and cortical neurons seeded in 96-well plates for 24 h at 37° C.
The MTT reduction assay was performed as described [60] . Preformed oligomers of HypF-N (12 µM monomer concentration) were incubated in cell culture medium for 1 h in the absence or presence of Clu or α 2 M (HypF-N:chaperone molar ratio was 10:1 and 100:1 for Clu and α 2 M, respectively) and then added to rat neurons for 24 h.
Measurement of intracellular Ca
2+ and ROS in cultured neurons
Preformed oligomers of Aβ 42 (12 µM monomer concentration) were incubated for 0 h and 1 h in the cell culture medium with or without Clu or α 2 M (oligomer:chaperone molar ratios as described above) and then added to rat neurons seeded on glass coverslips for 60 min at 37 °C. Preformed oligomers of HypF-N (12 µM monomer concentration) were incubated for 1 h in the cell culture medium with or without Clu or α 2 M (oligomer:chaperone molar ratios as described above) and then added to rat neurons seeded on glass coverslips for 60 min at 37 °C. To detect intracellular Ca 2+ and ROS production, neurons were then loaded with Fluo3-AM (Molecular Probes, Milan, Italy) or with 2',7'-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA, Molecular Probes, Milan, Italy), respectively, as described previously [60, 61] . Cell fluorescence was analysed by the confocal scanning microscope described in the Materials and Methods section.
Colocalisation of Aβ 42 aggregates with PSD-95 in cultured neurons
Preformed oligomers of HypF-N (12 µM monomer concentration) were incubated for 1 h in the cell culture medium with or without Clu or α 2 M (HypF-N:chaperone molar ratio as described 
